SCHEMBL25940696

SCHEMBL25940696

CCOC(=O)c1c(C)n(C)c2ncc(OC)cc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.50
▸ POLB P06746 3/20 0.50
▸ ATM Q13315 1/20 0.49
▸ HPGD P15428 2/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MAPT P10636 3/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PDE4D Q08499 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ S1PR2 O95136 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25941246 0.89 SMN1; SMN2 (0.50) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL25940711 0.85 ALOX5 (0.44) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL25941342 0.84 HSD17B10 (0.49) SMN1; SMN2HSD17B10ALDH1A1POLBHPGD
SCHEMBL25941343 0.83 SMN1; SMN2 (0.47) SMN1; SMN2HSD17B10ALDH1A1POLBHPGD
SCHEMBL25938395 0.80 SMN1; SMN2 (0.40) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL25948520 0.80 MAPT (0.40) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL9557007 0.76 SMN1; SMN2 (0.76) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL30875172 0.76 SMN1; SMN2 (0.76) SMN1; SMN2HSD17B10ALDH1A1POLBATM
SCHEMBL16377046 0.76 KMT2A (0.48) SMN1; SMN2HSD17B10ALDH1A1POLBHPGD
SCHEMBL25941252 0.76 SMN1; SMN2 (0.42) SMN1; SMN2HSD17B10ALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4209492-A1 COMPOUND FOR TREATING THROMBOTIC DISEASES Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-07-12 — — EP disclosed
Send feedback